©2024 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma